FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 25

Author

Admin 422 posts 0 comments

Whitepaper

The future of financial services: better customer experiences start with…

Admin Apr 9, 2025
Over the last few years, consumers have shown extraordinary resilience through much uncertainty. Many have adapted…
Whitepaper

How Finance & Accounting Teams Can Enable Digital Transformation

Admin Apr 8, 2025
Finance and accounting leaders are increasingly being called to do more and serve as strategic advisors to the…
Featured News

Stock Market Crash: ₹13 Lakh Crore Investor Wealth Wiped Out as Markets Plunge

Admin Apr 7, 2025
Today, April 7, 2025, global stock markets experienced significant declines, primarily driven by escalating trade…
Whitepaper

Buy Now, Pay Later: Market trends and consumer impacts

Admin Apr 2, 2025
Consumers have long used credit instruments to purchase goods and services. In recent years, a fast-growing…
Whitepaper

2025 Retail Banking Report

Admin Apr 1, 2025
Get more insights: 2025 World Retail Banking Report from Capgemini 67% of banking executives say prompt,…
Whitepaper

New global retail banking data

Admin Mar 31, 2025
Explore what’s new in retail banking: Download new Capgemini research Only 9% of prospects convert to…
Whitepaper

Fintech Predictions for 2025 with Plaid

Admin Mar 28, 2025
Get ahead of your 2025 goals with Plaid Co-founder and CEO Zach Perret’s predictions for fintech. You’ll get…
Whitepaper

2024 DevSecOps Report: Finserv

Admin Mar 27, 2025
The financial services industry has some unique challenges and needs when it comes to DevSecOps — including…
Whitepaper

Core Banking Modernization in Europe—Taking the Composable Route

Admin Mar 26, 2025
Founded in 1896, Barclays is among the world's oldest banks and enjoys the patronage of some of Europe's most…
Whitepaper

Innovation is Crucial to the Success of Finance & Accounting

Admin Mar 25, 2025
Companies can innovate in any number of ways. They can design new products, embark on new market strategies,…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI

    ARTICLE

    Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
    2026-05-14T11:15:00Z
    Announced Positive 12-month Follow-on Data for Iopofosine I 131 in relapsed/refractory Waldenström Macroglobulinemia (r/r WM)


    Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-14T11:05:00Z
    Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV® study presented today at ASGCT 2026 Annual Meeting along with initial rese-cel...


    Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-14T11:01:00Z
    NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the first quarter ended March 31, 2026, and recent business highlights.


    ASHA and Hilarity for Charity Collaborate in Free, Online Event for Dementia Caregivers on May 20
    2026-05-14T11:01:00Z
    Rockville, Md., May 14, 2026 (GLOBE NEWSWIRE) -- Communication difficulties are one of the hallmarks of dementia, and they can be among the more challenging everyday aspects for caregivers.


    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
    2026-05-14T11:00:00Z
    WILMINGTON, Del., May 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will release its first quarter...


    Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026
    2026-05-14T11:00:00Z
    BERKELEY HEIGHTS, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully integrated, commercial biotechnology company, today announced a poster presentation...


    Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
    2026-05-14T11:00:00Z
    NOVATO, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Cyclarity Therapeutics, Inc., a clinical stage biopharmaceutical company engineering cyclodextrin molecules into simple, scalable, and affordable therapies that bind and remove toxic...


    EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
    2026-05-14T11:00:00Z
    – LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after –


    CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
    2026-05-14T11:00:00Z
    CMP-002 administration resulted in a statistically significant improvement in seizure phenotypes and parameters in a SYNGAP1 haploinsufficient mouse model


    XORTX Announces US$5 Million Public Offering
    2026-05-14T11:00:00Z
    CALGARY, Alberta, May 14, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing...


    Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
    2026-05-14T11:00:00Z
    ATLANTA, May 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today...


    American Shared Hospital Services Reports First Quarter 2026 Financial Results
    2026-05-14T11:00:00Z
    15.9% Revenue Growth Driven by Direct Patient Services Expansion; Operating Performance Improves Year-Over-Year


    BrewDog Shakes Up RTD Shelves Across the UK with New Nostalgia-Led Wonderland Cocktails
    2026-05-14T11:00:00Z
    Introducing Pear Drop Margarita & Fizzy Toffee Apple Martini


    Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
    2026-05-14T11:00:00Z
    Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System Atrophy


    GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-14T11:00:00Z
    DUBLIN, May 14, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression,...


    Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
    2026-05-14T11:00:00Z
    WELLESLEY HILLS, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced an upcoming...


    Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
    2026-05-14T11:00:00Z
    A single infusion of the lowest dose of rese-cel administered without preconditioning, after discontinuation of all immunomodulators, demonstrated compelling drug-free responses for 6 months in 2 of 4 refractory patients;...


    Pelthos Therapeutics Announces First Quarter 2026 Financial Results
    2026-05-14T11:00:00Z
    ZELSUVMI® net product revenue grew 17% quarter over quarter from $9.1 million in the fourth quarter of 2025 to $10.7 million in the first quarter of 2026


    Hyperion DeFi Reports 1Q 2026 Financial Results with Record Net Income and Raises Guidance for Full Year 2026
    2026-05-14T11:00:00Z
    Company Reports Record $8.8M Net Income and $19.5M Adjusted EBITDA(8)


    Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update
    2026-05-14T11:00:00Z
    BALA CYNWYD, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported its first...


    Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
    2026-05-14T11:00:00Z
    New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence multiple inflammatory pathways.


    Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
    2026-05-14T11:00:00Z
    Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring


    Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
    2026-05-14T11:00:00Z
    Updated micvotabart pelidotin (MICVO) Phase 1 monotherapy data in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) on track for mid-year 2026; update to include analyses focused on...


    Indivior to Participate in Upcoming Investor Conferences
    2026-05-14T11:00:00Z
    RICHMOND, Va., May 14, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences:


    4basebio Announces Appointment of Chief Financial Officer and Board Changes
    2026-05-14T11:00:00Z
    Cambridge, UK, 14 May 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the appointment of Richard Bungay as Chief...


    Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease
    2026-05-14T10:59:00Z
    CELIA did not meet its primary endpoint assessing dose response; based on the strength of the biomarker and efficacy data, Biogen plans to advance diranersen to registrational development


    Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-14T10:30:00Z
    ~ Achieved First Quarter 2026 Total Net Revenues of $15.1 Million, Up 73% Year Over Year ~


    Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting
    2026-05-14T10:01:00Z
    New data demonstrate promising preclinical safety profile and durable LDL-C lowering of ≥90% with single dose of EDIT-401 in non-human primates through ~6 months


    Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium
    2026-05-14T05:30:00Z
    PARIS, FRANCE, 14 May 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the presentation of the Phase II LANTIC trial for the first aesthetic glabellar lines indication with corabotase, a custom-designed molecule recognized as the first in...


    Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
    2026-05-14T03:21:29Z
    SHANGHAI, May 14, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Shanghai Tenry Pharmaceutical Co., Ltd. (“Tenry...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.